Boundless Bio director, 10% owner Kevin Tang buys $349k in shares
Alpha Vantage · Investing.com India · · AI-summarised by FinFlash
Kevin Tang, a director and 10% owner of Boundless Bio, Inc. (BOLD), recently purchased approximately $349,592 worth of common stock through entities he controls in October 2026. These transactions occurred between October 16 and October 20, at prices ranging from $2.33 to $2.37 per share. Following these purchases, Mr. Tang's entities beneficially own 2,990,109 shares of Boundless Bio.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.